Growth Metrics

BioCorRx (BICX) Change in Accured Expenses (2016 - 2025)

BioCorRx (BICX) has disclosed Change in Accured Expenses for 12 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 24994.32% to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $286839.0 through Dec 2025, down 80.11% year-over-year, with the annual reading at $286839.0 for FY2025, 80.11% down from the prior year.
  • Change in Accured Expenses hit -$1.5 million in Q4 2025 for BioCorRx, down from $868743.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $934022.0 in Q2 2025 to a low of -$1.5 million in Q4 2025.
  • Historically, Change in Accured Expenses has averaged $203440.9 across 5 years, with a median of $253073.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 527.58% in 2023 and later plummeted 24994.32% in 2025.
  • Year by year, Change in Accured Expenses stood at $307991.0 in 2021, then tumbled by 46.83% to $163767.0 in 2022, then increased by 25.55% to $205612.0 in 2023, then crashed by 102.97% to -$6106.0 in 2024, then tumbled by 24994.32% to -$1.5 million in 2025.
  • Business Quant data shows Change in Accured Expenses for BICX at -$1.5 million in Q4 2025, $868743.0 in Q3 2025, and $934022.0 in Q2 2025.